ALL HCC cases | Comparison of viral-HCC vs. viral marker negative HCC | |||
---|---|---|---|---|
n = (645) | ||||
Mean ± SD/n (%) | Viral HCC (n = 546) | Viral marker negative HCC(n = 99) | P value | |
Duration between diagnosis of cirrhosis & HCC(months) | ||||
00 | 291(45.1) | 226(41.4) | 65(65.7) | <0.001 |
1-55 | 243(37.7) | 219(40.1) | 24(24.2) | |
>55 | 111(17.2) | 101(18.5) | 10(10.1) | |
Mode of diagnosis | ||||
On screening | 53(8.2) | 52(9.5) | 1(1.0) | 0.001 |
Incidental | 57(8.8) | 44(8.1) | 13(13.1) | |
Symptomatic | 535(82.9) | 450(82.4) | 85(85.9) | |
Stage of HCC | ||||
Non-advance | 240(37.2%) | 222(40.7) | 18(18.2) | <0.001 |
Advance | 405(62.8%) | 324(59.3) | 81(81.8) | |
Macroscopic types | ||||
Solitary | 246(38.1) | 213(39.0) | 33(33.3) | 0.04 |
Paucifical (≤ 3 nodules) | 259(40.2) | 223(40.8) | 36(36.4) | |
Multifocal(>3 nodules) | 96(14.9) | 79(14.5) | 17(17.2) | |
Massive/infiltrative | 44(6.8%) | 31(5.7) | 13(13.1) | |
Maximum tumor size (cm) | ||||
< 5 | 359(55.65) | 326(59.7) | 33(33.3) | <0.001 |
5-10 | 213(33.02) | 173(31.7) | 40(40.4) | |
>10 | 73(11.31) | 47(8.6) | 26(26.3) | |
Hepatic lobes | ||||
Left | 81(12.6) | 69(12.6) | 12(12.1) | 0.98 |
Right | 387(60) | 327(59.9) | 60(60.6) | |
Both | 177(27.4) | 150(27.5) | 27(27.3) | |
PVT | ||||
No | 429(66.5) | 359(65.8) | 70(70.7) | 0.33 |
Yes | 216(33.5) | 187(34.2) | 29(29.3) | |
Extra hepatic spread | ||||
No | 560(86.8) | 479(87.7) | 81(81.8) | 0.12 |
Yes | 85(13.2) | 67(12.3) | 18(18.2) |